<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Low Extrem Wounds</journal-id><journal-id journal-id-type="iso-abbrev">Int J Low Extrem Wounds</journal-id><journal-id journal-id-type="publisher-id">IJL</journal-id><journal-id journal-id-type="hwp">spijl</journal-id><journal-title-group><journal-title>The International Journal of Lower Extremity Wounds</journal-title></journal-title-group><issn pub-type="ppub">1534-7346</issn><issn pub-type="epub">1552-6941</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">36069031</article-id><article-id pub-id-type="pmc">PMC10018408</article-id>
<article-id pub-id-type="doi">10.1177/15347346221122859</article-id><article-id pub-id-type="publisher-id">10.1177_15347346221122859</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Outcomes of Hallux Amputation Versus Partial First Ray Resection in People with Non-Healing Diabetic Foot Ulcers: A Pragmatic Observational Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5901-8964</contrib-id><name><surname>Blanchette</surname><given-names>Virginie</given-names></name><degrees>DPM, PhD</degrees><xref rid="aff1-15347346221122859" ref-type="aff">1</xref><xref rid="aff3-15347346221122859" ref-type="aff">3</xref><xref rid="corresp1-15347346221122859" ref-type="corresp">*</xref><xref rid="corresp1-15347346221122859" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Houde</surname><given-names>Louis</given-names></name><degrees>PhD</degrees><xref rid="aff2-15347346221122859" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Armstrong</surname><given-names>David G.</given-names></name><degrees>DPM, MD, PhD</degrees><xref rid="aff3-15347346221122859" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2561-9243</contrib-id><name><surname>Schmidt</surname><given-names>Brian M.</given-names></name><degrees>DPM</degrees><xref rid="aff4-15347346221122859" ref-type="aff">4</xref></contrib></contrib-group><aff id="aff1-15347346221122859">
<label>1</label>Department of Human Kinetics and Podiatric Medicine, <institution-wrap><institution-id institution-id-type="Ringgold">14847</institution-id><institution content-type="university">Universit&#x000e9; du Qu&#x000e9;bec &#x000e0; Trois-Rivi&#x000e8;res</institution></institution-wrap>, 3351, boul. des Forges, C.P. 500, Trois-Rivi&#x000e8;res, Canada, G9A 5H7</aff><aff id="aff2-15347346221122859">
<label>2</label>Department of Mathematic and Informatic, <institution-wrap><institution-id institution-id-type="Ringgold">14847</institution-id><institution content-type="university">Universit&#x000e9; du Qu&#x000e9;bec &#x000e0; Trois-Rivi&#x000e8;res</institution></institution-wrap>, 3351, boul. des Forges, C.P. 500, Trois-Rivi&#x000e8;res, Canada, G9A 5H7</aff><aff id="aff3-15347346221122859">
<label>3</label>Southwestern Academic Limb Salvage Alliance (SALSA), Department of Surgery, <institution-wrap><institution-id institution-id-type="Ringgold">12223</institution-id><institution content-type="university">Keck School of Medicine of University of Southern California</institution></institution-wrap>, 1520 San Pablo, St. Los Angeles, CA, 90031, USA</aff><aff id="aff4-15347346221122859">
<label>4</label><institution-wrap><institution-id institution-id-type="Ringgold">166144</institution-id><institution content-type="university">University of Michigan Medical School</institution></institution-wrap>, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, Domino&#x02019;s Farms (Lobby C, Suite 1300) 24 Frank Lloyd Wright Drive, Ann Arbor, MI, 48106, USA</aff><author-notes><corresp id="corresp1-15347346221122859">Virginie Blanchette, Universit&#x000e9; du Qu&#x000e9;bec &#x000e0; Trois-Rivi&#x000e8;res, Department of Human Kinetics and Podiatric Medicine, 3351, boul. des Forges, C.P. 500, Trois-Rivi&#x000e8;res, Canada, G9A 5H7. 
Email: <email>Virginie.Blanchette@uqtr.ca</email>
</corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><volume>24</volume><issue>1</issue><issue-title>Special Issue: Lower-extremity surgery and amputations</issue-title><fpage>225</fpage><lpage>234</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p>There are few data comparing outcomes after hallux amputation or partial first ray resection after diabetic foot ulcer (DFU). In a similar context, the choice to perform one of these two surgeries is attributable to clinician preference based on experience and characteristics of the patient and the DFU. Therefore, the purpose of this study was to determine the more definitive surgery between hallux amputation and partial first ray resection. We abstracted data from a cohort of 70 patients followed for a 1-year postoperative period to support clinical practice. We also attempted to identify patient characteristics leading to these outcomes. Our results suggested no statistical difference between the type of surgery and outcomes such as recurrence of DFU and amputation at 3, 6, and 12 months or death. However, there was a statistically significantly increased likelihood of re-ulceration for patients with CAD who underwent hallux amputation (p&#x02009;=&#x02009;0.02). There was also a significantly increased likelihood of re-ulceration for people with depression or a history when the partial ray resection was performed (p =&#x02009;0.02). Patients with prior amputation showed a higher probability of undergoing another re-amputation with partial ray resection (p&#x02009;=&#x02009;0.01). Although the trends that emerge from this project are limited to what is observed in this statistical context, where the number of patients included and the number of total observations per outcome were limited, it highlights interesting data for future research to inform clinical decisions to support best practices for the benefit of patients.</p></abstract><kwd-group><kwd>diabetes</kwd><kwd>lower extremity</kwd><kwd>foot diseases</kwd><kwd>orthopedic procedures</kwd><kwd>reoperation</kwd><kwd>infection</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>typesetter</meta-name><meta-value>ts19</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Diabetes mellitus (DM) is one of the most common chronic diseases worldwide. DM-related foot complications such as peripheral arterial disease, diabetic foot infection (DFI), diabetic foot ulcer (DFU) and minor or major lower extremity amputation (LEA) reduce the quality of life and lead to premature death.<sup><xref rid="bibr1-15347346221122859" ref-type="bibr">1</xref>,<xref rid="bibr2-15347346221122859" ref-type="bibr">2</xref></sup> Personal, societal and economic burdens of DFUs highlight the importance to support prevention strategies for the at-risk population as well as effective treatments that will prevent DFU recurrence, re-amputation or other complications such DFI and death.<sup><xref rid="bibr3-15347346221122859" ref-type="bibr">3</xref>,<xref rid="bibr4-15347346221122859" ref-type="bibr">4</xref></sup> Indeed, DFI is involved in 58% of DFU and approximately 50% of these infected patients are affected with PAD. PAD is highly predictive of LEA.<sup><xref rid="bibr5-15347346221122859" ref-type="bibr">5</xref><xref rid="bibr6-15347346221122859" ref-type="bibr"/><xref rid="bibr7-15347346221122859" ref-type="bibr"/>&#x02013;<xref rid="bibr8-15347346221122859" ref-type="bibr">8</xref></sup> Approximately 17% to 30% of people with a DFU will ultimately require a LEA and patients with DFI have 155 times greater risk of LEA than patients without associated infection.<sup><xref rid="bibr3-15347346221122859" ref-type="bibr">3</xref>,<xref rid="bibr7-15347346221122859" ref-type="bibr">7</xref>,<xref rid="bibr9-15347346221122859" ref-type="bibr">9</xref>,<xref rid="bibr10-15347346221122859" ref-type="bibr">10</xref></sup> It is estimated that 85% of all DM-related LEA are preceded by a DFU but sometime, LEAs are an inevitable treatment.<sup>
<xref rid="bibr11-15347346221122859" ref-type="bibr">11</xref>
</sup></p><p>The key components of successful limb salvage are to achieve a DFU-free, plantigrade foot that is functional with treatments that have minimum impact on a patient&#x02019;s global health. A successful LEA is i) the complete eradication of nonviable tissue to optimize the patient healing potential, ii) reduce the risk of DFU recurrence (or new DFU onset) and iii) avoid the need for extended local wound care or repeat surgical interventions.<sup><xref rid="bibr12-15347346221122859" ref-type="bibr">12</xref>,<xref rid="bibr13-15347346221122859" ref-type="bibr">13</xref></sup> The goal of isolated partial-foot amputation, such as a hallux amputation and a partial first ray resection, is to maintain bipedal ambulatory status and function.<sup><xref rid="bibr14-15347346221122859" ref-type="bibr">14</xref>,<xref rid="bibr15-15347346221122859" ref-type="bibr">15</xref></sup> Minor LEA are preferred to major LEA because of their association with less morbidity and mortality.<sup><xref rid="bibr16-15347346221122859" ref-type="bibr">16</xref>,<xref rid="bibr17-15347346221122859" ref-type="bibr">17</xref></sup> The forefoot has been reported as the most frequent location of DFI in DM.<sup>
<xref rid="bibr18-15347346221122859" ref-type="bibr">18</xref>
</sup> Furthermore, the metatarsophalangeal joint of the hallux, including sesamoid bones, is more complex from an anatomical perspective than the lesser metatarsophalangeal joints. Such differences in anatomy might impact surgical outcomes.<sup>
<xref rid="bibr18-15347346221122859" ref-type="bibr">18</xref>
</sup></p><p>However, first ray amputations (eg, hallux disarticulation and/or partial first ray amputation) impact a patient&#x02019;s gait pattern because of the absence of the propulsive phase provided by now altered medial column of the foot.<sup><xref rid="bibr19-15347346221122859" ref-type="bibr">19</xref>,<xref rid="bibr20-15347346221122859" ref-type="bibr">20</xref></sup> Although those procedures seem to affect gait less than a more proximal LEA, published studies have reported that patients who undergo partial first ray resection often progress to requiring a more proximal repeat LEA.<sup><xref rid="bibr13-15347346221122859" ref-type="bibr">13</xref>,<xref rid="bibr21-15347346221122859" ref-type="bibr">21</xref></sup> Moreover, following hallux amputation, subsequent higher level of amputation is frequently observed due to new infected DFU associated diabetes limited joint mobility and new ambulatory pattern because of the amputated hallux.<sup>
<xref rid="bibr22-15347346221122859" ref-type="bibr">22</xref>
</sup></p><p>Furthermore, the literature comparing outcomes following hallux amputation or partial first ray resection are limited.<sup>
<xref rid="bibr15-15347346221122859" ref-type="bibr">15</xref>
</sup> In similar context, the choice to perform one of these two surgeries is attributable to the clinician&#x02019;s decision according to their experience, to the patient&#x02019;s DFU characteristics and patient&#x02019;s preference through informed consent. Hence, guidelines are suggesting clinical decision based on several factors (eg, functional, infection and vascular status, bone quality, presence of infection, etc) with the intent to preserve as much of the limb as possible.<sup><xref rid="bibr23-15347346221122859" ref-type="bibr">23</xref><xref rid="bibr24-15347346221122859" ref-type="bibr"/><xref rid="bibr25-15347346221122859" ref-type="bibr"/><xref rid="bibr26-15347346221122859" ref-type="bibr"/><xref rid="bibr27-15347346221122859" ref-type="bibr"/>&#x02013;<xref rid="bibr28-15347346221122859" ref-type="bibr">28</xref></sup> The aim was to determine the most definitive surgery between hallux amputation and partial first ray resection for patients with infected ulcer (+&#x02009;/-) osteomyelitis involving the first ray who were followed for 1-year postoperatively. Our primary objective was to compare DFU events (at the surgical site and/or the ipsilateral foot only) at 3-, 6- and 12-months following the surgical intervention in patients who had hallux amputation or partial first ray resection. Our secondary aim was to compare other outcomes between both cohorts (eg, infection, re-amputation, death). We hypothesized hallux amputation would be most definitive and result in less complications during the 1-year follow up, in line with similar trends from previous studies.<sup><xref rid="bibr19-15347346221122859" ref-type="bibr">19</xref>,<xref rid="bibr21-15347346221122859" ref-type="bibr">21</xref></sup> It have been reported that patients who undergo partial first ray resection often progress to requiring a more proximal re-amputation.<sup>
<xref rid="bibr21-15347346221122859" ref-type="bibr">21</xref>
</sup></p><sec id="section2-15347346221122859"><title>Materials and Methods</title><p>We performed a observational cohort investigation (retrospective; level of evidence III) which mined and analyzed big data, with coding, from single unified Electronic Medical Records (EMR) at University of Michigan Health System, a large tertiary academic health system overseeing the care of more than 80,000 patients with DM.<sup>
<xref rid="bibr29-15347346221122859" ref-type="bibr">29</xref>
</sup> Between 2016 and 2020, 70 patients from which 26 had hallux amputation and 44, a partial first ray resection, were retrieved from database and followed for longitudinal outcomes on a one-year period. According to sample size calculation, 38 to 216 patients are sufficient power for confidence interval between 90&#x02013;95% in the conservative proportion of LEA (17%).<sup>
<xref rid="bibr30-15347346221122859" ref-type="bibr">30</xref>
</sup> All patients underwent comprehensive medical treatment and surgical intervention by a multidisciplinary team, which included five board-certified podiatric surgeons (for the amputations), nurses, vascular surgeons, and structured and targeted diabetic foot care according to the International Working Group on Diabetic Foot recommendations (IWGDF).<sup>
<xref rid="bibr24-15347346221122859" ref-type="bibr">24</xref>
</sup></p><p>Inclusion criteria were adult DM patients age &#x02265;18 with a concomitant diabetic foot surgery whether hallux amputation or partial first ray resection that EMR reported data over a 1-year period. Our EMR mining system was programmed to include limb salvage procedural codes, based on Common Procedure Terminology (CPT) for higher-level amputations (CPT 84.13-84.19), minor lower extremity amputations (CPT 84.10-84.12). The hallux amputation is defined as the level of amputation distal to the first metatarsophalangeal, including the hallux and the joint.<sup><xref rid="bibr15-15347346221122859" ref-type="bibr">15</xref>,<xref rid="bibr17-15347346221122859" ref-type="bibr">17</xref>,<xref rid="bibr31-15347346221122859" ref-type="bibr">31</xref></sup> Partial first ray resection is defined as the primary amputation of the hallux phalanxes and at least a part of the first metatarsus, distal to the first metatarsal&#x02013;cuneiform joint and excluded additional digital amputations.<sup><xref rid="bibr14-15347346221122859" ref-type="bibr">14</xref>,<xref rid="bibr17-15347346221122859" ref-type="bibr">17</xref>,<xref rid="bibr21-15347346221122859" ref-type="bibr">21</xref></sup></p><sec id="section2A-15347346221122859"><title>Outcomes Measures</title><p>Data collected included demographic information (eg, age, sex, race, body mass index, coronary heart disease, hypertension, etc (<xref rid="table1-15347346221122859" ref-type="table">Table&#x000a0;1</xref>). The outcome measures were related DFU healing after the LEA on a 1-year period. DFU healing was defined as a continuous, viable epithelial covering over the entire previously open wound, subsequently within 2&#x02009;months with no new ulcerations. Complications associated with each surgical approach (DFU at 3-, 6- and 12 months, re-amputation at 3-,6-and 12- months and death) were also collected.</p><table-wrap position="float" id="table1-15347346221122859"><label>Table&#x000a0;1.</label><caption><p>Baseline characteristics of patients who had partial first ray resection or hallux amputation</p></caption><alternatives><graphic xlink:href="10.1177_15347346221122859-table1" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">Total<break/>(n&#x02009;=&#x02009;70)</th><th align="left" rowspan="1" colspan="1">Partial First Ray Resection<break/>(n&#x02009;=&#x02009;44)</th><th align="left" rowspan="1" colspan="1">Hallux amputation<break/>(n&#x02009;=&#x02009;26)</th><th align="left" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age, years, mean&#x02009;&#x000b1;&#x02009;SD</td><td rowspan="1" colspan="1">57.4&#x02009;&#x000b1;&#x02009;11.0</td><td rowspan="1" colspan="1">56.3&#x02009;&#x000b1;&#x02009;10.6</td><td rowspan="1" colspan="1">59.3&#x02009;&#x000b1;&#x02009;11.2</td><td rowspan="1" colspan="1">0.27</td></tr><tr><td rowspan="1" colspan="1">Sex, % Men (n)</td><td rowspan="1" colspan="1">85.7 (60)</td><td rowspan="1" colspan="1">86.4 (38)</td><td rowspan="1" colspan="1">84.6 (22)</td><td rowspan="1" colspan="1">0.84</td></tr><tr><td rowspan="1" colspan="1">Race, % (n)<break/>&#x02003;Caucasian<break/>&#x02003;Others<sup>&#x02020;</sup></td><td rowspan="1" colspan="1"><break/>78.6 (55)<break/>21.4 (15)</td><td rowspan="1" colspan="1"><break/>70.5 (31)<break/>29.5 (13)</td><td rowspan="1" colspan="1"><break/>92.3 (24)<break/>7.7 (2)</td><td rowspan="1" colspan="1"><break/>0.03*<break/><break/></td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) mean&#x02009;&#x000b1;&#x02009;SD</td><td rowspan="1" colspan="1">32.8&#x02009;&#x000b1;&#x02009;7.0</td><td rowspan="1" colspan="1">32.4&#x02009;&#x000b1;&#x02009;7.0</td><td rowspan="1" colspan="1">33.4&#x02009;&#x000b1;&#x02009;7.2</td><td rowspan="1" colspan="1">0.58</td></tr><tr><td rowspan="1" colspan="1">Previous Amputation % (n)</td><td rowspan="1" colspan="1">27.1 (19)</td><td rowspan="1" colspan="1">27.3 (12)</td><td rowspan="1" colspan="1">26.9 (7)</td><td rowspan="1" colspan="1">0.22</td></tr><tr><td rowspan="1" colspan="1">Presence of SIRS % (n)</td><td rowspan="1" colspan="1">11.4 (8)</td><td rowspan="1" colspan="1">11.4 (5)</td><td rowspan="1" colspan="1">11.5 (3)</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">IDSA Classification<sup>
<xref rid="bibr25-15347346221122859" ref-type="bibr">25</xref>
</sup>% (n)<break/>&#x02003;1&#x000a0;: None<break/>&#x02003;2&#x000a0;: Mild<break/>&#x02003;3&#x000a0;: Moderate<break/>&#x02003;4&#x000a0;: Severe</td><td rowspan="1" colspan="1">1.4 (1)<break/>41.4 (29)<break/>45.7 (32)<break/>11.4 (8)</td><td rowspan="1" colspan="1">0 (0)<break/>36.4 (16)<break/>50 (22)<break/>13.6 (6)</td><td rowspan="1" colspan="1">3.8 (1)<break/>50.0 (13)<break/>38.5 (10)<break/>7.7 (2)</td><td rowspan="1" colspan="1">&#x0003e; 0.5</td></tr><tr><td rowspan="1" colspan="1">Presence of OM<sup>&#x02021;</sup></td><td rowspan="1" colspan="1">91.3 (63)</td><td rowspan="1" colspan="1">93.2 (41)</td><td rowspan="1" colspan="1">88.0 (22)</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">CAD % (n)</td><td rowspan="1" colspan="1">44.3 (31)</td><td rowspan="1" colspan="1">45.5 (20)</td><td rowspan="1" colspan="1">42.3 (11)</td><td rowspan="1" colspan="1">0.19</td></tr><tr><td rowspan="1" colspan="1">HTN % (n)</td><td rowspan="1" colspan="1">35.7 (25)</td><td rowspan="1" colspan="1">34.1 (15)</td><td rowspan="1" colspan="1">38.4 (10)</td><td rowspan="1" colspan="1">0.72</td></tr><tr><td rowspan="1" colspan="1">CKD stage, % (n)<break/>&#x02003;Stage 0 (no CKD)<break/>&#x02003;(GFR &#x0003e; 90 mL/min)<break/>&#x02003;Stage 1<break/>&#x02003;(GFR&#x02009;=&#x02009;60&#x02013;89 mL/min)<break/>&#x02003;Stage 2<break/>&#x02003;(GFR&#x02009;=&#x02009;45&#x02013;59 mL/min)<break/>&#x02003;Stage 3<break/>&#x02003;(GFR&#x02009;=&#x02009;30&#x02013;44 mL/min)<break/>&#x02003;Stage 4<break/>&#x02003;(GFR&#x02009;=&#x02009;15&#x02013;29 mL/min)<break/>&#x02003;Stage 5 CKD<break/>&#x02003;(GFR &#x0003c;15 mL/min)</td><td rowspan="1" colspan="1">
57.1 (40)<break/>
35.7 (25)<break/>
1.4 (1)<break/>
2.9 (2)<break/>
1.4(1)<break/>
1.4 (1)</td><td rowspan="1" colspan="1"><break/>63.6 (28)<break/>
27.3 (12)<break/>
0 (0)<break/>
2.5 (2)<break/>
2.3 (1)<break/>
2.3 (1)<break/><break/></td><td rowspan="1" colspan="1">
46.2 (12)<break/>
50.0 (13)<break/>
3.8 (1)<break/>
0 (0)<break/>
0 (0)<break/>
0 (0)</td><td rowspan="1" colspan="1">
&#x0003e; 0.5
</td></tr><tr><td rowspan="1" colspan="1">Smoking, % (n)</td><td rowspan="1" colspan="1">32.9 (23)</td><td rowspan="1" colspan="1">31.8 (14)</td><td rowspan="1" colspan="1">34.6 (9)</td><td rowspan="1" colspan="1">0.81</td></tr><tr><td rowspan="1" colspan="1">DPN</td><td rowspan="1" colspan="1">91.4 (64)</td><td rowspan="1" colspan="1">93.2 (41)</td><td rowspan="1" colspan="1">88.5 (23)</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">PLT, K/uL, mean&#x02009;&#x000b1;&#x02009;SD</td><td rowspan="1" colspan="1">267.8&#x02009;&#x000b1;&#x02009;118.4</td><td rowspan="1" colspan="1">277.5&#x02009;&#x000b1;&#x02009;133.9</td><td rowspan="1" colspan="1">251.4&#x02009;&#x000b1;&#x02009;86.4</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="1" colspan="1">HBG g/dL, mean&#x02009;&#x000b1;&#x02009;SD</td><td rowspan="1" colspan="1">11.7&#x02009;&#x000b1;&#x02009;1.8</td><td rowspan="1" colspan="1">11.4&#x02009;&#x000b1;&#x02009;2.0</td><td rowspan="1" colspan="1">12.1&#x02009;&#x000b1;&#x02009;1.3</td><td rowspan="1" colspan="1">0.02*</td></tr><tr><td rowspan="1" colspan="1">ESR mm/hr, mean&#x02009;&#x000b1;&#x02009;SD<sup>#</sup></td><td rowspan="1" colspan="1">73.6&#x02009;&#x000b1;&#x02009;36.3</td><td rowspan="1" colspan="1">82.35&#x02009;&#x000b1;&#x02009;37.3</td><td rowspan="1" colspan="1">58.9&#x02009;&#x000b1;&#x02009;27.7</td><td rowspan="1" colspan="1">0.04*</td></tr><tr><td rowspan="1" colspan="1">MCV fI, mean&#x02009;&#x000b1;&#x02009;SD</td><td rowspan="1" colspan="1">86.4&#x02009;&#x000b1;&#x02009;6.6</td><td rowspan="1" colspan="1">85.6&#x02009;&#x000b1;&#x02009;6.4</td><td rowspan="1" colspan="1">87.7&#x02009;&#x000b1;&#x02009;6.9</td><td rowspan="1" colspan="1">0.82</td></tr><tr><td rowspan="1" colspan="1">Glucose mg/dL, mean&#x02009;&#x000b1;&#x02009;SD<sup>&#x000b6;</sup></td><td rowspan="1" colspan="1">206.5&#x02009;&#x000b1;&#x02009;125.1</td><td rowspan="1" colspan="1">228.1&#x02009;&#x000b1;&#x02009;136.4</td><td rowspan="1" colspan="1">170.9&#x02009;&#x000b1;&#x02009;95.6</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">C-RP mg/dL, mean&#x02009;&#x000b1;&#x02009;SD<sup>&#x000a5;</sup></td><td rowspan="1" colspan="1">11.5&#x02009;&#x000b1;&#x02009;9.7</td><td rowspan="1" colspan="1">13.09&#x02009;&#x000b1;&#x02009;9.5</td><td rowspan="1" colspan="1">8.65&#x02009;&#x000b1;&#x02009;9.6</td><td rowspan="1" colspan="1">0.98</td></tr><tr><td rowspan="1" colspan="1">TBI, mean ratio (amputation side when possible)<sup>&#x000a7;</sup></td><td rowspan="1" colspan="1">0.55&#x02009;&#x000b1;&#x02009;0.24</td><td rowspan="1" colspan="1">0.51&#x02009;&#x000b1;&#x02009;0.25</td><td rowspan="1" colspan="1">0.63&#x02009;&#x000b1;&#x02009;0.17</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">Non compressible vessel due to calcification<sup>&#x000a7;</sup></td><td rowspan="1" colspan="1">22.2 (12)</td><td rowspan="1" colspan="1">22.9 (8)</td><td rowspan="1" colspan="1">22.2 (4)</td><td rowspan="1" colspan="1">0.99</td></tr><tr><td rowspan="1" colspan="1">Previous revascularization, % (n)</td><td rowspan="1" colspan="1">11.4 (8)</td><td rowspan="1" colspan="1">15.0 (6)</td><td rowspan="1" colspan="1">7.7 (2)</td><td rowspan="1" colspan="1">0.45</td></tr><tr><td rowspan="1" colspan="1">Depression<sup>&#x00026;</sup> % (n)</td><td rowspan="1" colspan="1">15.7 (11)</td><td rowspan="1" colspan="1">15.9 (7)</td><td rowspan="1" colspan="1">15.4 (4)</td><td rowspan="1" colspan="1">0.95</td></tr><tr><td rowspan="1" colspan="1">Ulcer classification (UT)<sup>
<xref rid="bibr35-15347346221122859" ref-type="bibr">35</xref>
</sup> previous to amputation, % (n)<break/>&#x02003;1B<break/>&#x02003;2B<break/>&#x02003;2C<break/>&#x02003;2D<break/>&#x02003;3A<break/>&#x02003;3B<break/>&#x02003;3C<break/>&#x02003;3D<break/>&#x02003;4B<break/>&#x02003;4D<break/>&#x02003;Missing data</td><td rowspan="1" colspan="1"><break/>2.9 (2)<break/>17.1 (12)<break/>1.9 (1)<break/>7.1 (5)<break/>4.3 (3)<break/>27.1 (19)<break/>1.9 (1)<break/>8.6 (6)<break/>12.9 (9)<break/>4.3 (3)<break/>12.9 (9)</td><td rowspan="1" colspan="1"><break/>2.3 (1)<break/>9.1 (4)<break/>0 (0)<break/>11.4 (5)<break/>2.3 (1)<break/>27.3 (12)<break/>0 (0)<break/>11.4 (5)<break/>18.1 (8)<break/>4.5 (2)<break/>13.6 (6)</td><td rowspan="1" colspan="1"><break/>3.8 (1)<break/>30.8 (8)<break/>3.8 (1)<break/>0 (0)<break/>7.7 (2)<break/>26.9 (7)<break/>3.8 (1)<break/>3.8 (1)<break/>3.8 (1)<break/>3.8 (1)<break/>11.5 (3)</td><td rowspan="1" colspan="1">&#x0003e; 0.05</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-15347346221122859"><p>Legend:</p></fn><fn id="table-fn2-15347346221122859"><label>
<sup>&#x02020;</sup>
</label><p>Black or Asian people</p></fn><fn id="table-fn3-15347346221122859"><label>
<sup>&#x02021;</sup>
</label><p>Calculated with n&#x02009;=&#x02009;69 (1 missing datum for the hallux amputation group)</p></fn><fn id="table-fn4-15347346221122859"><p>* Statistically significant</p></fn><fn id="table-fn5-15347346221122859"><label>
<sup>#</sup>
</label><p>Calculated with n&#x02009;=&#x02009;62 (2 missing data for hallux amputation group and 4 missing data for partial ray resection group).</p></fn><fn id="table-fn6-15347346221122859"><label>
<sup>&#x000b6;</sup>
</label><p>Calculated with n&#x02009;=&#x02009;69 (1 missing datum for the partial ray resection group)</p></fn><fn id="table-fn7-15347346221122859"><label>
<sup>&#x000a5;</sup>
</label><p>Calculated with n&#x02009;=&#x02009;66 (2 missing data for hallux amputation group and 4 for the partial ray resection group)</p></fn><fn id="table-fn8-15347346221122859"><label>
<sup>&#x000a7;</sup>
</label><p>Calculated with n&#x02009;=&#x02009;14 for hallux amputation group (7 missing data and 4 calcification values) and n&#x02009;=&#x02009;27 for partial ray resection group (9 missing data and 8 calcification values)</p></fn><fn id="table-fn9-15347346221122859"><label>
<sup>&#x00026;</sup>
</label><p>Depression was diagnosed by the team using the DMS-V criteria, a tool and reference guide for mental health clinicians to diagnose, classify, and identify mental health conditions.</p></fn><fn id="table-fn10-15347346221122859"><p>Abbreviations:</p></fn><fn id="table-fn11-15347346221122859"><p>SD: Standard Deviation; BMI: Body Mass Index; OM: Osteomyelitis confirmed by radiograph or Magnetic Resonance Imagery; CAD: Coronary Arterial Disease; HTN: Hypertension; SIRS: Systemic Inflammatory Response Syndrome; CKD: Chronic Kidney Disease; GFR: Glomerular Filtration Rate; DPN: Diabetic peripheral neuropathy suspected by loss of protective sensation and clinical findings; MCV: Mean corpuscular volume; HBG: hemoglobin; ESR: erythrocytes sedimentation rate; PLT: Platelet level; CR-P: C-Reactive Protein Level; TBI: Toe-Brachial Index</p></fn></table-wrap-foot></table-wrap></sec><sec id="section2B-15347346221122859"><title>Data Analysis</title><p>Demographic data were analyzed using descriptive statistics. To compare the grades both groups, the characteristics were analyzed using chi square (<italic toggle="yes">&#x003c7;</italic>2). Re-ulceration and re-amputation (or better ulcer-free and amputation-free survival) are time-dependent measures that can be reported as Kaplan-Meier curves. However, our retrospective data have allowed only time estimates (in months; not precise, as they were agglomerated). Since we cannot be very precise related to the time, which is important in Kaplan-Meier curves, we performed Mann-Whitney U test (non-parametric) and Friedman test on the independent samples to compare the means of the quantitative variables related to the outcomes. When the sample sizes were not sufficient to the accurate p-value we did adjustment using a bootstrap method. We performed a multivariate logistic regression per variable for patients&#x02019; characteristics known to be predictor factors for DFU and LEA according to the literature and our previous work.<sup>
<xref rid="bibr32-15347346221122859" ref-type="bibr">32</xref>
</sup> Odd ratio was the association measure for continuous data. The <italic toggle="yes">&#x003c7;</italic>2 was used to measure the independence of the dichotomous and multinomials variables between surgical type (hallux amputation or partial ray resection), the outcomes (cumulative re-ulceration or re-amputation) related to the variable interest. Odd ratios cannot be calculated in this statistical context. This was expressed using proportion. The death as outcomes could not be assessed with the regression because there were too few events for the sample size. P-value inferior to 0.05 was considered a significant association between outcomes and those factors in this analysis. This study is reported according to the STROCSS 2019 guidelines.<sup>
<xref rid="bibr33-15347346221122859" ref-type="bibr">33</xref>
</sup> It was approved by the Institutional Review Board (HUM00108607) and it was completed in accordance with the ethical standards of the Ethics Committee. We used SPSS Statistics software 27 (IBM Corp, New York, United States) to perform the analysis.</p></sec></sec><sec sec-type="results" id="section3-15347346221122859"><title>Results</title><sec id="section3A-15347346221122859"><title>Demographics and Clinical Characteristics</title><p>A total of 70 patients who underwent first ray amputation surgery or hallux amputation were included in the study. The total cohort is mainly Caucasian (78.8%) male (85.7%) with an average age of 57.4 years (<xref rid="table1-15347346221122859" ref-type="table">Table&#x000a0;1</xref>). DFU clinical presentation during hospital admission was primarily used to determine necessity of operative intervention. Ten patients (38.4%) in the hallux cohort and fifteen patients (34.1%) in the partial first ray cohort had index DFU on the left foot requiring surgical intervention. Neuropathic wound etiologies accounted for 92.2% and 88.5% in the hallux and partial first ray amputation cohorts, respectively. Although we had missing data for the vascular component, calcified vessels accounted for 22.2% and limited accurate reporting of vascular status. It is known at least 11.4% of the cohort had prior revascularization and ischemia was mild to moderate.<sup>
<xref rid="bibr34-15347346221122859" ref-type="bibr">34</xref>
</sup> However, the majority of DFU were classified according to the University of Texas classification which accounts for an ischemic component of the index DFU (ie, class C or D).<sup>
<xref rid="bibr35-15347346221122859" ref-type="bibr">35</xref>
</sup> All patients except one (in the partial ray resection cohort) were ambulatory prior to the amputation.</p><p>Pre-operative imaging was obtained in all patients to assist in operative planning. Radiographs were obtained in all patients and advanced imaging via magnetic resonance imaging (MRI) was obtained in 25 (56.8%) and 18 (69.2%) in the partial first ray and hallux amputations cohorts, respectively (p&#x02009;&#x0003e;&#x02009;0.05). The rates of OM diagnosed was (93.2 .0% v. 88.0%, p&#x02009;=&#x02009;0.25). Prior to amputation, Charlson Comorbidity Index (CCI) values (5.4&#x02009;&#x000b1;&#x02009;3.5 v. 4.7&#x02009;&#x000b1;&#x02009;2.6; p&#x02009;&#x0003e;&#x02009;0.05), IDSA classification at time of admission (2.5&#x02009;&#x000b1;&#x02009;0.7 v. 2.8&#x02009;&#x000b1;&#x02009;0.7; p&#x02009;&#x0003e;&#x02009;0.32), leukocyte count (9.4&#x02009;&#x000b1;&#x02009;4.6 v. 12&#x02009;&#x000b1;&#x02009;6.9; p&#x02009;&#x0003e;&#x02009;0.05) were similar. Patient characteristics were relatively similar and did not reach statistical significance (p&#x02009;&#x0003e;&#x02009;0.05) for all variables (<xref rid="table1-15347346221122859" ref-type="table">Table&#x000a0;1</xref>). Inflammatory markers including erythrocyte sedimentation rate (ESR) and C-reactive protein (C-RP) demonstrated divergence in our population. ESR demonstrated increased elevation in the partial ray group versus the hallux cohort (58.9&#x02009;&#x000b1;&#x02009;27.7 v. 82.4&#x02009;&#x000b1;&#x02009;37.3 p&#x02009;=&#x02009;0.04), but the acute phase reactant C-RP did not demonstrate a difference (8.6&#x02009;&#x000b1;&#x02009;9.6 v. 13.1&#x02009;&#x000b1;&#x02009;9.5; p&#x02009;=&#x02009;0.98). The partial first ray resection group was more ethnically diverse (29.5% v. 7.2%; p&#x02009;=&#x02009;0.03) and also had a lower hemoglobin level (11.4&#x02009;&#x000b1;&#x02009;2.0 v. 12.1&#x02009;&#x000b1;&#x02009;1,3; p&#x02009;=&#x02009;0.02).</p></sec><sec id="section3B-15347346221122859"><title>Outcomes</title><p>Of the 70 patients, all had defined primary outcomes at 1 year (<xref rid="table2-15347346221122859" ref-type="table">Table&#x000a0;2</xref>). In the hallux amputation group, six (23%), three (12%), and two (8%) developed ulcer recurrence within 3-, 6-, and 12 months post-operatively, respectively. Similarly, in the partial ray group, 16 (36%), 8 (18%), and 6 (14%) developed re-ulceration within 3-, 6-, and 12-months postoperative follow-up, respectively. The difference among cohorts did not reach statistical significance. Re-amputation occurred in 0, 3 (12%), and 0 patients and 6(14%), 5(11%), and 1 (2%) in the hallux and partial first ray amputation groups, respectively, at 3-, 6-, and 12-months follow-up periods. The difference in rate of re-amputation was not significant at any time point in longitudinal follow-up. Additionally, two patients in the hallux amputation group and four in the partial first ray amputation group died; no deaths were related to surgical intervention or foot infection.</p><table-wrap position="float" id="table2-15347346221122859"><label>Table&#x000a0;2.</label><caption><p>Primary outcomes comparison</p></caption><alternatives><graphic xlink:href="10.1177_15347346221122859-table2" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">3-month ulcer n (%)</th><th align="left" rowspan="1" colspan="1">3-month amputation 
n (%)</th><th align="left" rowspan="1" colspan="1">6-month ulcer n (%)</th><th align="left" rowspan="1" colspan="1">6-month amputation 
n (%)</th><th align="left" rowspan="1" colspan="1">12-month ulcer n (%)</th><th align="left" rowspan="1" colspan="1">12-month amputation n (%)</th><th align="left" rowspan="1" colspan="1">Death<sup>&#x02020;</sup> 
n (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Partial First Ray Resection 
(n&#x02009;=&#x02009;44)</bold>
</td><td rowspan="1" colspan="1">16 (36)</td><td rowspan="1" colspan="1">6 (14)</td><td rowspan="1" colspan="1">8 (18)</td><td rowspan="1" colspan="1">5 (11)</td><td rowspan="1" colspan="1">6 (14)</td><td rowspan="1" colspan="1">1 (2)</td><td rowspan="1" colspan="1">4 (9)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Hallux Amputation 
(n&#x02009;=&#x02009;26)</bold>
</td><td rowspan="1" colspan="1">6 (23)</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">3 (12)</td><td rowspan="1" colspan="1">3 (12)</td><td rowspan="1" colspan="1">2 (8)</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">2 (8)</td></tr><tr><td rowspan="1" colspan="1">
<bold>p-value</bold>
</td><td rowspan="1" colspan="1">0.295</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.521</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.701</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn12-15347346221122859"><p>Legend&#x000a0;:</p></fn><fn id="table-fn13-15347346221122859"><label>
<sup>&#x02020;</sup>
</label><p>During the year following the indexed amputation surgery.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section3C-15347346221122859"><title>Factors Associated with Outcomes and Surgical Procedures</title><p>Although the association was not statically significant for chronic kidney disease (CKD) (<xref rid="table3-15347346221122859" ref-type="table">Table&#x000a0;3</xref>), a trend was observed in the association between having a re-ulceration at one-year and having undergone partial ray resection amputation versus hallux amputation (OR 4.15 vs 0.53; p&#x02009;&#x0003e;&#x02009;0.05). In terms of baseline demographic, clinical and laboratory characteristics, only three factors were found to influence outcomes with statistically significant differences (<xref rid="table4-15347346221122859" ref-type="table">Table&#x000a0;4</xref>). Patients had a higher probability of re-ulceration in the hallux amputation cohort (54.5%; p&#x02009;=&#x02009;0.02) if they had coronary artery disease (CAD). The same was not true in the partial ray resection cohort (45.0%; p&#x02009;=&#x02009;0.96). For patients with current or a history of depression (not specified in the EMR), the partial first ray resection cohort had more re-ulcerations (85.7%; p&#x02009;=&#x02009;0.02) compared with the likelihood of the hallux cohort (50%; p&#x02009;=&#x02009;0.37). A higher probability to have a re-amputation was found for patient in the partial ray resection cohort (58.3%; p&#x02009;=&#x02009;0.01) compared to the other cohort probability (14.3%; p&#x02009;=&#x02009;0.79) when they presented with a prior history of amputation.</p><table-wrap position="float" id="table3-15347346221122859"><label>Table&#x000a0;3.</label><caption><p>Logistic regression for continuous data: relationship between surgical type, the outcomes (re-ulceration or re-amputation) and related to the variable.</p></caption><alternatives><graphic xlink:href="10.1177_15347346221122859-table3" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">Surgery Types</th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td colspan="4" rowspan="1">Total ulceration (3-, 6- and 12-months)</td></tr><tr><td rowspan="2" colspan="1">Age</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.46</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.01</td><td rowspan="1" colspan="1">0.57</td></tr><tr><td rowspan="2" colspan="1">BMI</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.16</td><td rowspan="1" colspan="1">0.44</td></tr><tr><td rowspan="2" colspan="1">PLT</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.91</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="2" colspan="1">HBG</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.26</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.27</td><td rowspan="1" colspan="1">0.98</td></tr><tr><td rowspan="2" colspan="1">MCV</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.04</td><td rowspan="1" colspan="1">0.67</td></tr><tr><td rowspan="2" colspan="1">TBI<sup>&#x02020;</sup></td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">0.79</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.71</td><td rowspan="1" colspan="1">0.97</td></tr><tr><td rowspan="2" colspan="1">Glucose</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.57</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.54</td></tr><tr><td rowspan="2" colspan="1">ESR</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.27</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.04</td><td rowspan="1" colspan="1">0.54</td></tr><tr><td rowspan="2" colspan="1">C-RP</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.95</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.44</td></tr><tr><td rowspan="2" colspan="1">CKD</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.13</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">4.15</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td colspan="4" rowspan="1">Re-amputation (3-, 6- and 12-months)</td></tr><tr><td rowspan="2" colspan="1">Age</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">0.19</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">0.98</td></tr><tr><td rowspan="2" colspan="1">BMI</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.13</td><td rowspan="1" colspan="1">0.26</td></tr><tr><td rowspan="2" colspan="1">PLT</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.74</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">0.97</td></tr><tr><td rowspan="2" colspan="1">HBG</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">0.85</td></tr><tr><td rowspan="2" colspan="1">MCV</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.23</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.17</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="2" colspan="1">TBI</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1">0.37</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">0.86</td></tr><tr><td rowspan="2" colspan="1">Glucose</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.94</td></tr><tr><td rowspan="2" colspan="1">ESR</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">0.13</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="2" colspan="1">CRP</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.62</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.01</td><td rowspan="1" colspan="1">0.65</td></tr><tr><td rowspan="2" colspan="1">CKD</td><td rowspan="1" colspan="1">HA</td><td rowspan="1" colspan="1">1.25</td><td rowspan="1" colspan="1">0.43</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.94</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn14-15347346221122859"><p>Legend:</p></fn><fn id="table-fn15-15347346221122859"><label>
<sup>&#x02020;</sup>
</label><p>Calculated with n&#x02009;=&#x02009;13 for hallux amputation group (8 missing data) and n&#x02009;=&#x02009;27 for partial ray resection group (9 missing data), excluding 13 patients with non-compressible vessel due to calcification (see table 1)</p></fn><fn id="table-fn16-15347346221122859"><p>Abbreviations:</p></fn><fn id="table-fn17-15347346221122859"><p>OR: Odd Ratio; HA: Hallux amputation; PRR: Partial Ray Resection; BMI: Body Mass Index; PLT: Platelet level; HBG: hemoglobin; MCV: Mean corpuscular volume; TBI: Toe-Brachial Index; ESR: Erythrocytes Sedimentation Rate; CR-P: C-Reactive Protein Level</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="table4-15347346221122859"><label>Table&#x000a0;4.</label><caption><p>Probability of re-ulceration or re-amputation with dichotomous and multinomial variables by amputation type</p></caption><alternatives><graphic xlink:href="10.1177_15347346221122859-table4" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">Surgery types</th><th align="left" rowspan="1" colspan="1">Proportion, %</th><th align="left" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td colspan="4" rowspan="1">Total ulceration (3-, 6- and 12-months)</td></tr><tr><td rowspan="2" colspan="1">Sex (men)</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">27.3</td><td rowspan="1" colspan="1">0.37</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">42.1</td><td rowspan="1" colspan="1">0.26</td></tr><tr><td rowspan="2" colspan="1">Race (Caucasian)</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">33.3</td><td rowspan="1" colspan="1">0.33</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">0.43</td></tr><tr><td rowspan="2" colspan="1">Previous amputation</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">42.9</td><td rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">58.3</td><td rowspan="1" colspan="1">0.29</td></tr><tr><td rowspan="2" colspan="1">SIRS</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.22</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">0.81</td></tr><tr><td rowspan="2" colspan="1">OM</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">27.3</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">46.3</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="2" colspan="1">IDSA 1; 2; 3; 4</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0; 7.8; 50.0; 50.0</td><td rowspan="1" colspan="1">0.26</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0; 56.3; 40.9; 33.3</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="2" colspan="1">CAD</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">54.5</td><td rowspan="1" colspan="1">0.02*</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">45.0</td><td rowspan="1" colspan="1">0.96</td></tr><tr><td rowspan="2" colspan="1">HTN</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">16.7</td><td rowspan="1" colspan="1">0.39</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">42.9</td><td rowspan="1" colspan="1">0.74</td></tr><tr><td rowspan="2" colspan="1">Smokers</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">55.6</td><td rowspan="1" colspan="1">0.46</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">42.9</td><td rowspan="1" colspan="1">0.81</td></tr><tr><td rowspan="2" colspan="1">DPN</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">30.4</td><td rowspan="1" colspan="1">0.92</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">46.6</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="2" colspan="1">Previous vascularization</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.33</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">0.81</td></tr><tr><td rowspan="2" colspan="1">Depression</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">0.37</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">85.7</td><td rowspan="1" colspan="1">0.02*</td></tr><tr><td colspan="4" rowspan="1">Re-amputation (3-, 6- and 12-months)</td></tr><tr><td rowspan="2" colspan="1">Sex (men)</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">13.6</td><td rowspan="1" colspan="1">0.43</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">23.7</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="2" colspan="1">Race (Caucasian)</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">12.5</td><td rowspan="1" colspan="1">0.60</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">25.0</td><td rowspan="1" colspan="1">0.47</td></tr><tr><td rowspan="2" colspan="1">Previous amputation</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">14.3</td><td rowspan="1" colspan="1">0.79</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">58.3</td><td rowspan="1" colspan="1">0.01*</td></tr><tr><td rowspan="2" colspan="1">SIRS</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">50.0</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="2" colspan="1">OM</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">9.1</td><td rowspan="1" colspan="1">0.23</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">29.3</td><td rowspan="1" colspan="1">0.27</td></tr><tr><td rowspan="2" colspan="1">IDSA<sup>
<xref rid="bibr25-15347346221122859" ref-type="bibr">25</xref>
</sup> 1; 2; 3; 4</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0; 7.7; 20; 0</td><td rowspan="1" colspan="1">0.73</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">0; 25.0; 27.3; 33.3</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="2" colspan="1">CAD</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">18.2</td><td rowspan="1" colspan="1">0.36</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">35.0</td><td rowspan="1" colspan="1">0.29</td></tr><tr><td rowspan="2" colspan="1">HTN</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.31</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">14.3</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="2" colspan="1">Smokers</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">22.2</td><td rowspan="1" colspan="1">0.22</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">28.6</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="2" colspan="1">DPN</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">13.0</td><td rowspan="1" colspan="1">0.51</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">29.3</td><td rowspan="1" colspan="1">0.27</td></tr><tr><td rowspan="2" colspan="1">Previous vascularization</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.60</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">33.3</td><td rowspan="1" colspan="1">0.72</td></tr><tr><td rowspan="2" colspan="1">Depression</td><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">25.0</td><td rowspan="1" colspan="1">0.36</td></tr><tr><td rowspan="1" colspan="1">PRR</td><td rowspan="1" colspan="1">28.6</td><td rowspan="1" colspan="1">0.93</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn18-15347346221122859"><p>Legend:</p></fn><fn id="table-fn19-15347346221122859"><p>* Statistically significant</p></fn><fn id="table-fn20-15347346221122859"><p>Abbreviations:</p></fn><fn id="table-fn21-15347346221122859"><p>SIRS: Systemic Inflammatory Response Syndrome; OM: Osteomyelitis; IDSA: Infection Disease Society of America Classification; CAD: Coronary Arterial Disease; HTN: Hypertension; DPN: Diabetic Peripheric Neuropathy; SIRS: Systemic Inflammatory Response Syndrome.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="section4-15347346221122859"><title>Discussion</title><p>This study reported outcome difference between hallux amputation and partial first ray resection in a retrospective patient cohort of 70 patients followed on 1-year postoperative period and intended to support decision-making. Although the groups were slightly different at the baseline, especially related to two laboratory tests (HBG and ESR), the characteristics of the DFU, age and sex were similar. HBG and ESR, respectively associated with anemia and infection, are recognized as markers of morbidity and mortality in patients with DFU and to increase amputation risk.<sup><xref rid="bibr36-15347346221122859" ref-type="bibr">36</xref>,<xref rid="bibr37-15347346221122859" ref-type="bibr">37</xref></sup> Moreover, there was a greater population&#x02019;s diversity in the partial ray resection cohort, which could have also influenced the results. Indeed, it is well known that some ethnicity undergo more major amputations.<sup>
<xref rid="bibr38-15347346221122859" ref-type="bibr">38</xref>
</sup> Recent studies have demonstrated that American Africans have more minor LEA when they have DFU infection, but there is less LEA in the Asian population.<sup><xref rid="bibr39-15347346221122859" ref-type="bibr">39</xref>,<xref rid="bibr40-15347346221122859" ref-type="bibr">40</xref></sup> As a result, we would have expected to observe more outcomes in the partial ray resection group. However, our results did not show significant differences related to re-ulceration, re-amputation, or death. Thus, our results are partially in agreement with those of a previous study specifically on partial first ray amputation, which reported this type of surgery often progresses to a more proximal LEA and increases the risk of DFU.<sup>
<xref rid="bibr19-15347346221122859" ref-type="bibr">19</xref>
</sup></p><p>In the context of this study, we identified factors such as depression and CAD are associated with more re-ulceration depending on the type of surgery. Patient with previous amputation was also associated with more re-amputation in the partial ray resection group which is consistent with previous study.<sup>
<xref rid="bibr21-15347346221122859" ref-type="bibr">21</xref>
</sup> Moreover, depression was also highlighted as a predictor to LEA.<sup>
<xref rid="bibr41-15347346221122859" ref-type="bibr">41</xref>
</sup> While not statistically significant, a partial ray first resection with CKD can lead to more re-ulceration compared to the hallux amputation (OR 4.15 vs 0.53). Our results are again consistent with a previous systematic review.<sup>
<xref rid="bibr42-15347346221122859" ref-type="bibr">42</xref>
</sup> Therefore, these findings suggest a partial first ray resection should be avoided in patients with the following characteristics: CKD, depression or a history, and a previous amputation. It may support, to some extent when the presentation of the infection permits, the clinical decision to avoid this surgical procedure to reduce the likelihood of a poor (future) prognosis.</p><p>Overall, approximately 59% of patients had a re-ulceration and 21% had a re-amputation within one year in our cohort. In parallel with earlier literature reports which demonstrate approximately 60% of patients will need further LEA and 46% will have an DFU recurrence.<sup><xref rid="bibr13-15347346221122859" ref-type="bibr">13</xref>,<xref rid="bibr43-15347346221122859" ref-type="bibr">43</xref>,<xref rid="bibr44-15347346221122859" ref-type="bibr">44</xref></sup> However, the mortality rate of approximately 9% was lower than the one reported in a recent systematic review (approximately 20%).<sup>
<xref rid="bibr42-15347346221122859" ref-type="bibr">42</xref>
</sup> This positive finding can be justified by the diabetic foot management at our institution including a specialized service with a team approach to diabetic foot disease including podiatry.<sup>
<xref rid="bibr45-15347346221122859" ref-type="bibr">45</xref>
</sup> This approach has been recognized to improve diabetic foot outcomes and enhance quality of care.<sup><xref rid="bibr46-15347346221122859" ref-type="bibr">46</xref>,<xref rid="bibr47-15347346221122859" ref-type="bibr">47</xref></sup> Although this is a hypothesis, the lower mortality rate should be further explored, particularly as the data from this project did not allow for differentiation of major and minor LEA as outcomes. It is recognized that mortality and poor quality of life are higher in DM patients who undergo major LEAs.<sup>
<xref rid="bibr3-15347346221122859" ref-type="bibr">3</xref>
</sup> This type of data would have been informative and represents a limitation.</p><p>There are also other limitations to this study. First, this is an observational study; therefore, there is no control group and some missing data (<xref rid="table1-15347346221122859" ref-type="table">Table&#x000a0;1</xref>). Second, providers chose surgical intervention based on clinical appearance and radiographic findings. There was no structured algorithm to guide surgeons in their decision-making, and thus the dataset was dependent on standard of care as described by IWGDF. However, there were only five board-certified surgeons involved and reduced bias in decision-making and limited excessive heterogeneity. In fact, the design of the study is pragmatic in that it aims to answer a practical clinical question to support decision-making and potentially is helpful to guide therapy.</p><p>More specific continuous measurement variables, such as albumin and (absolute) toe pressures, were not available for comparison and a better understanding of the vascular and healing potential are essential. However, these are not routinely performed in inpatient assessment at our institution. In addition, analysis was complicated by missing data but also because of the low number of events at each time of follow-up. Additional information on these variables collected at uniform timelines could provide improved granularity into optimal procedure selection for a given patient. The statistical context limits the generalizability of the results. However, further prospective study in this area could also inform, in addition to health outcomes, about benefit, harms, adverse events and satisfaction or other patient-related outcomes to better support shared-clinical decisions (between patients and providers) in DFI context. This study highlighted future hypotheses exploration such as whether the complication rates of hallux amputations are worse first in a particular population (ie, with CAD or other comorbidities /risk factors), and thus whether these individuals should have a partial first ray amputation at the first place to achieve the best outcome.</p><p>To date, the decision to perform a partial first ray amputation or hallux amputation (disarticulation) was based on provider decision-making and not evidence-based medicine with respect to outcomes. Our cohort, although small (n&#x02009;=&#x02009;70), demonstrates no significant difference in patient outcomes at one-year following surgical intervention. This included outcomes such as re-ulceration, re-amputation, and death. When faced with an infected ulcer (&#x02009;+&#x02009;/-) osteomyelitis involving the first ray, if the infection can be eradicated through the removal of additional bone (partial first ray instead of hallux amputation), this decision is supported by evidence to be as safe as a hallux disarticulation without additional long-term sequelae of the operation from this study. However, consideration should be given when the patient outlined characteristics identified by this study. From an overall perspective, lower mortality at 1-year of our cohort supports the importance of team management of this health issue.</p></sec><sec id="section5-15347346221122859"><title>Conclusion</title><p>This study highlights interesting data to inform clinical decisions to support best practices for the benefit of patients with respect to osteomyelitis in the first ray. Future research should guide surgeons in their decision-making to incorporate evidence-based medicine approaches to diabetic foot infections <italic toggle="yes">before</italic> intervention rather than to continue to operate blindly with respect to eventual clinical outcomes.</p></sec></body><back><fn-group><fn fn-type="other"><p><bold>Declarations:</bold> Ethics approval and consent to participate</p><p>University of Michigan, Ann Arbor IRB HUM00108607</p></fn><fn fn-type="other"><p><bold>Availability of Data and Materials:</bold> Data will be provided on demand.</p></fn><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> BS is co-investigator on National Institute of Diabetes and Digestive and Kidney Diseases grants (U01DK119083)</p></fn><fn fn-type="other"><p><bold>ORCID iDs:</bold> Virginie Blanchette <ext-link xlink:href="https://orcid.org/0000-0002-5901-8964" ext-link-type="uri">https://orcid.org/0000-0002-5901-8964</ext-link></p><p>Brian M. Schmidt <ext-link xlink:href="https://orcid.org/0000-0002-2561-9243" ext-link-type="uri">https://orcid.org/0000-0002-2561-9243</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-15347346221122859"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
<name><surname>Swerdlow</surname><given-names>MA</given-names></name>
<name><surname>Armstrong</surname><given-names>AA</given-names></name>
<name><surname>Conte</surname><given-names>MS</given-names></name>
<name><surname>Padula</surname><given-names>WV</given-names></name>
<name><surname>Bus</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer</article-title>. <source>J Foot Ankle Res.</source>
<year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>4</lpage>.<pub-id pub-id-type="pmid">31956341</pub-id>
</mixed-citation></ref><ref id="bibr2-15347346221122859"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sothornwit</surname><given-names>J</given-names></name>
<name><surname>Srisawasdi</surname><given-names>G</given-names></name>
<name><surname>Suwannakin</surname><given-names>A</given-names></name>
<name><surname>Sriwijitkamol</surname><given-names>A</given-names></name>
</person-group>. <article-title>Decreased health-related quality of life in patients with diabetic foot problems</article-title>. <source>Diabetes, Metab Syndr Obes: Targets Ther.</source>
<year>2018</year>;<volume>11</volume>:<fpage>35</fpage>-<lpage>43</lpage>.</mixed-citation></ref><ref id="bibr3-15347346221122859"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
<name><surname>Boulton</surname><given-names>AJ</given-names></name>
<name><surname>Bus</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Diabetic foot ulcers and their recurrence</article-title>. <source>N Engl J Med.</source>
<year>2017</year>;<volume>376</volume>(<issue>24</issue>):<fpage>2367</fpage>-<lpage>2375</lpage>.<pub-id pub-id-type="pmid">28614678</pub-id>
</mixed-citation></ref><ref id="bibr4-15347346221122859"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soo</surname><given-names>BP</given-names></name>
<name><surname>Rajbhandari</surname><given-names>S</given-names></name>
<name><surname>Egun</surname><given-names>A</given-names></name>
<name><surname>Ranasinghe</surname><given-names>U</given-names></name>
<name><surname>Lahart</surname><given-names>IM</given-names></name>
<name><surname>Pappachan</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Survival at 10 years following lower extremity amputations in patients with diabetic foot disease</article-title>. <source>Endocrine</source>. 2020;69(1):100&#x02013;106.</mixed-citation></ref><ref id="bibr5-15347346221122859"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hicks</surname><given-names>CW</given-names></name>
<name><surname>Selvin</surname><given-names>E</given-names></name>
</person-group>. <article-title>Epidemiology of peripheral neuropathy and lower extremity disease in diabetes</article-title>. <source>Curr Diab Rep.</source>
<year>2019</year>;<volume>19</volume>(<issue>10</issue>):<fpage>1</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">30637535</pub-id>
</mixed-citation></ref><ref id="bibr6-15347346221122859"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prompers</surname><given-names>L</given-names></name>
<name><surname>Schaper</surname><given-names>N</given-names></name>
<name><surname>Apelqvist</surname><given-names>J</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study</article-title>. <source>Diabetologia</source>. <year>2008</year>;<volume>51</volume>(<issue>5</issue>):<fpage>747</fpage>-<lpage>755</lpage>.<pub-id pub-id-type="pmid">18297261</pub-id>
</mixed-citation></ref><ref id="bibr7-15347346221122859"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prompers</surname><given-names>L</given-names></name>
<name><surname>Huijberts</surname><given-names>M</given-names></name>
<name><surname>Apelqvist</surname><given-names>J</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the eurodiale study</article-title>. <source>Diabetologia</source>. <year>2007</year>;<volume>50</volume>(<issue>1</issue>):<fpage>18</fpage>-<lpage>25</lpage>.<pub-id pub-id-type="pmid">17093942</pub-id>
</mixed-citation></ref><ref id="bibr8-15347346221122859"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gazzaruso</surname><given-names>C</given-names></name>
<name><surname>Gallotti</surname><given-names>P</given-names></name>
<name><surname>Pujia</surname><given-names>A</given-names></name>
<name><surname>Montalcini</surname><given-names>T</given-names></name>
<name><surname>Giustina</surname><given-names>A</given-names></name>
<name><surname>Coppola</surname><given-names>A</given-names></name>
</person-group>. <article-title>Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: A 10-year retrospective cohort study</article-title>. <source>Endocrine</source>. <year>2021</year>;<volume>71</volume>(<issue>1</issue>):<fpage>59</fpage>-<lpage>68</lpage>.<pub-id pub-id-type="pmid">32712853</pub-id>
</mixed-citation></ref><ref id="bibr9-15347346221122859"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rastogi</surname><given-names>A</given-names></name>
<name><surname>Goyal</surname><given-names>G</given-names></name>
<name><surname>Kesavan</surname><given-names>R</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: Epidemiology of diabetic foot complications study</article-title>. <source>Diabetes Res Clin Pract.</source>
<year>2020</year>;<volume>162</volume>:<fpage>108113</fpage>.<pub-id pub-id-type="pmid">32165163</pub-id>
</mixed-citation></ref><ref id="bibr10-15347346221122859"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lavery</surname><given-names>LA</given-names></name>
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
<name><surname>Wunderlich</surname><given-names>RP</given-names></name>
<name><surname>Mohler</surname><given-names>MJ</given-names></name>
<name><surname>Wendel</surname><given-names>CS</given-names></name>
<name><surname>Lipsky</surname><given-names>BA</given-names></name>
</person-group>. <article-title>Risk factors for foot infections in individuals with diabetes</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>(<issue>6</issue>):<fpage>1288</fpage>-<lpage>1293</lpage>.<pub-id pub-id-type="pmid">16732010</pub-id>
</mixed-citation></ref><ref id="bibr11-15347346221122859"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hamilton</surname><given-names>EJ</given-names></name>
<name><surname>Davis</surname><given-names>WA</given-names></name>
<name><surname>Siru</surname><given-names>R</given-names></name>
<name><surname>Baba</surname><given-names>M</given-names></name>
<name><surname>Norman</surname><given-names>PE</given-names></name>
<name><surname>Davis</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Temporal trends in incident hospitalization for diabetes-related foot ulcer in type 2 diabetes: The fremantle diabetes study</article-title>. <source>Diabetes Care</source>. <year>2021</year>;<volume>44</volume>(<issue>3</issue>):<fpage>722</fpage>-<lpage>730</lpage>.<pub-id pub-id-type="pmid">33441420</pub-id>
</mixed-citation></ref><ref id="bibr12-15347346221122859"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wukich</surname><given-names>DK</given-names></name>
<name><surname>Raspovic</surname><given-names>KM</given-names></name>
</person-group>. <article-title>What role does function play in deciding on limb salvage versus amputation in patients with diabetes?</article-title>
<source>Plast Reconstr Surg.</source>
<year>2016</year>;<volume>138</volume>(<issue>3S</issue>):<fpage>188S</fpage>-<lpage>195S</lpage>.<pub-id pub-id-type="pmid">27556759</pub-id>
</mixed-citation></ref><ref id="bibr13-15347346221122859"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borkosky</surname><given-names>SL</given-names></name>
<name><surname>Roukis</surname><given-names>TS</given-names></name>
</person-group>. <article-title>Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: A systematic review</article-title>. <source>Diabet Foot Ankle.</source>
<year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>12169</fpage>.</mixed-citation></ref><ref id="bibr14-15347346221122859"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kadukammakal</surname><given-names>J</given-names></name>
<name><surname>Yau</surname><given-names>S</given-names></name>
<name><surname>Urbas</surname><given-names>W</given-names></name>
</person-group>. <article-title>Assessment of partial first-ray resections and their tendency to progress to transmetatarsal AmputationsA retrospective study</article-title>. <source>J Am Podiatr Med Assoc.</source>
<year>2012</year>;<volume>102</volume>(<issue>5</issue>):<fpage>412</fpage>-<lpage>416</lpage>.<pub-id pub-id-type="pmid">23001735</pub-id>
</mixed-citation></ref><ref id="bibr15-15347346221122859"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murdoch</surname><given-names>DP</given-names></name>
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
<name><surname>Dacus</surname><given-names>JB</given-names></name>
<name><surname>Laughlin</surname><given-names>TJ</given-names></name>
<name><surname>Morgan</surname><given-names>CB</given-names></name>
<name><surname>Lavery</surname><given-names>LA</given-names></name>
</person-group>. <article-title>The natural history of great toe amputations</article-title>. <source>J Foot Ankle Surg.</source>
<year>1997</year>;<volume>36</volume>(<issue>3</issue>):<fpage>204</fpage>-<lpage>208</lpage>.<pub-id pub-id-type="pmid">9232500</pub-id>
</mixed-citation></ref><ref id="bibr16-15347346221122859"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rathnayake</surname><given-names>A</given-names></name>
<name><surname>Saboo</surname><given-names>A</given-names></name>
<name><surname>Malabu</surname><given-names>UH</given-names></name>
<name><surname>Falhammar</surname><given-names>H</given-names></name>
</person-group>. <article-title>Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review</article-title>. <source>World J Diabetes.</source>
<year>2020</year>;<volume>11</volume>(<issue>9</issue>):<fpage>391</fpage>-<lpage>399</lpage>.<pub-id pub-id-type="pmid">32994867</pub-id>
</mixed-citation></ref><ref id="bibr17-15347346221122859"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Netten</surname><given-names>JJ</given-names></name>
<name><surname>Bus</surname><given-names>SA</given-names></name>
<name><surname>Apelqvist</surname><given-names>J</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Definitions and criteria for diabetic foot disease</article-title>. <source>Diabetes Metab Res Rev.</source>
<year>2020</year>;<volume>36</volume>(S1):<comment>e3268</comment>.</mixed-citation></ref><ref id="bibr18-15347346221122859"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cecilia-Matilla</surname><given-names>A</given-names></name>
<name><surname>L&#x000e1;zaro-Mart&#x000ed;nez</surname><given-names>JL</given-names></name>
<name><surname>Arag&#x000f3;n-S&#x000e1;nchez</surname><given-names>J</given-names></name>
<name><surname>Garc&#x000ed;a-&#x000c1;lvarez</surname><given-names>Y</given-names></name>
<name><surname>Chana-Valero</surname><given-names>P</given-names></name>
<name><surname>Beneit-Montesinos</surname><given-names>JV</given-names></name>
</person-group>. <article-title>Influence of the location of nonischemic diabetic forefoot osteomyelitis on time to healing after undergoing surgery</article-title>. <source>Int J Low Extrem Wounds.</source>
<year>2013</year>;<volume>12</volume>(<issue>3</issue>):<fpage>184</fpage>-<lpage>188</lpage>.<pub-id pub-id-type="pmid">24043680</pub-id>
</mixed-citation></ref><ref id="bibr19-15347346221122859"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aprile</surname><given-names>I</given-names></name>
<name><surname>Galli</surname><given-names>M</given-names></name>
<name><surname>Pitocco</surname><given-names>D</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Does first ray amputation in diabetic patients influence gait and quality of life?</article-title>
<source>J Foot Ankle Surg.</source>
<year>2018</year>;<volume>57</volume>(<issue>1</issue>):<fpage>44</fpage>-<lpage>51</lpage>.<pub-id pub-id-type="pmid">29268902</pub-id>
</mixed-citation></ref><ref id="bibr20-15347346221122859"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mann</surname><given-names>RA</given-names></name>
<name><surname>PoPPEN</surname><given-names>NK</given-names></name>
<name><surname>O'Konski</surname><given-names>M</given-names></name>
</person-group>. <article-title>Amputation of the great toe. A clinical and biomechanical study</article-title>. <source>Clin Orthop Relat Res.</source>
<year>1988</year>;<volume>226</volume>:<fpage>192</fpage>-<lpage>205</lpage>.</mixed-citation></ref><ref id="bibr21-15347346221122859"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borkosky</surname><given-names>SL</given-names></name>
<name><surname>Roukis</surname><given-names>TS</given-names></name>
</person-group>. <article-title>Incidence of repeat amputation after partial first ray amputation associated with diabetes mellitus and peripheral neuropathy: An 11-year review</article-title>. <source>J Foot Ankle Surg.</source>
<year>2013</year>;<volume>52</volume>(<issue>3</issue>):<fpage>335</fpage>-<lpage>338</lpage>.<pub-id pub-id-type="pmid">23540756</pub-id>
</mixed-citation></ref><ref id="bibr22-15347346221122859"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Hilaly</surname><given-names>R</given-names></name>
<name><surname>Elshazly</surname><given-names>O</given-names></name>
<name><surname>Amer</surname><given-names>A</given-names></name>
</person-group>. <article-title>The role of a total contact insole in diminishing foot pressures following partial first ray amputation in diabetic patients</article-title>. <source>The Foot</source>. <year>2013</year>;<volume>23</volume>(<issue>1</issue>):<fpage>6</fpage>-<lpage>10</lpage>.<pub-id pub-id-type="pmid">23266131</pub-id>
</mixed-citation></ref><ref id="bibr23-15347346221122859"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hingorani</surname><given-names>A</given-names></name>
<name><surname>LaMuraglia</surname><given-names>GM</given-names></name>
<name><surname>Henke</surname><given-names>P</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>The management of diabetic foot: A clinical practice guideline by the society for vascular surgery in collaboration with the American podiatric medical association and the society for vascular medicine</article-title>. <source>J Vasc Surg.</source>
<year>2016</year>;<volume>63</volume>(<issue>2</issue>):<fpage>3S</fpage>-<lpage>21S</lpage>.<pub-id pub-id-type="pmid">26804367</pub-id>
</mixed-citation></ref><ref id="bibr24-15347346221122859"><label>24</label><mixed-citation publication-type="journal">Schaper NC, van Netten JJ, Apelqvist J, <article-title>Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)</article-title>. <source>Diab Metab Res Rev</source>. <year>2020</year>;36(S1):<comment>e3266</comment>.</mixed-citation></ref><ref id="bibr25-15347346221122859"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lipsky</surname><given-names>BA</given-names></name>
<name><surname>Berendt</surname><given-names>AR</given-names></name>
<name><surname>Cornia</surname><given-names>PB</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>2012 Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections</article-title>. <source>Clin Infect Dis.</source>
<year>2012</year>;<volume>54</volume>(<issue>12</issue>):<comment>e132</comment>-<lpage>e173</lpage>.</mixed-citation></ref><ref id="bibr26-15347346221122859"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weledji</surname><given-names>EP</given-names></name>
<name><surname>Fokam</surname><given-names>P</given-names></name>
</person-group>. <article-title>Treatment of the diabetic foot&#x02013;to amputate or not?</article-title>
<source>BMC Surg.</source>
<year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">24401085</pub-id>
</mixed-citation></ref><ref id="bibr27-15347346221122859"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thorud</surname><given-names>JC</given-names></name>
<name><surname>Jupiter</surname><given-names>DC</given-names></name>
<name><surname>Lorenzana</surname><given-names>J</given-names></name>
<name><surname>Nguyen</surname><given-names>TT</given-names></name>
<name><surname>Shibuya</surname><given-names>N</given-names></name>
</person-group>. <article-title>Reoperation and reamputation after transmetatarsal amputation: A systematic review and meta-analysis</article-title>. <source>J Foot Ankle Surg.</source>
<year>2016</year>;<volume>55</volume>(<issue>5</issue>):<fpage>1007</fpage>-<lpage>1012</lpage>.<pub-id pub-id-type="pmid">27475711</pub-id>
</mixed-citation></ref><ref id="bibr28-15347346221122859"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skoutas</surname><given-names>D</given-names></name>
<name><surname>Papanas</surname><given-names>N</given-names></name>
<name><surname>Georgiadis</surname><given-names>G</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Risk factors for ipsilateral reamputation in patients with diabetic foot lesions</article-title>. <source>Int J Low Extrem Wounds.</source>
<year>2009</year>;<volume>8</volume>(<issue>2</issue>):<fpage>69</fpage>-<lpage>74</lpage>.<pub-id pub-id-type="pmid">19443895</pub-id>
</mixed-citation></ref><ref id="bibr29-15347346221122859"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>BM</given-names></name>
<name><surname>Wrobel</surname><given-names>JS</given-names></name>
<name><surname>Munson</surname><given-names>M</given-names></name>
<name><surname>Rothenberg</surname><given-names>G</given-names></name>
<name><surname>Holmes</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Podiatry impact on high-low amputation ratio characteristics: A 16-year retrospective study</article-title>. <source>Diabetes Research &#x00026; Clinical Practice</source>. <year>2017</year>;<volume>126</volume>:<fpage>272</fpage>-<lpage>277</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diabres.2017.02.008.</pub-id><pub-id pub-id-type="pmid">28288437</pub-id>
</mixed-citation></ref><ref id="bibr30-15347346221122859"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Charan</surname><given-names>J</given-names></name>
<name><surname>Biswas</surname><given-names>T</given-names></name>
</person-group>. <article-title>How to calculate sample size for different study designs in medical research?</article-title>
<source>Indian J Psychol Med.</source>
<year>2013</year>;<volume>35</volume>(<issue>2</issue>):<fpage>121</fpage>-<lpage>126</lpage>. doi:<pub-id pub-id-type="doi">10.4103/0253-7176.116232.</pub-id><pub-id pub-id-type="pmid">24049221</pub-id>
</mixed-citation></ref><ref id="bibr31-15347346221122859"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chu</surname><given-names>YJ</given-names></name>
<name><surname>Li</surname><given-names>XW</given-names></name>
<name><surname>Wang</surname><given-names>PH</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Clinical outcomes of toe amputation in patients with type 2 diabetes in tianjin, China</article-title>. <source>Int Wound J.</source>
<year>2016</year>;<volume>13</volume>(<issue>2</issue>):<fpage>175</fpage>-<lpage>181</lpage>.<pub-id pub-id-type="pmid">24629051</pub-id>
</mixed-citation></ref><ref id="bibr32-15347346221122859"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>BM</given-names></name>
<name><surname>McHugh</surname><given-names>JB</given-names></name>
<name><surname>Patel</surname><given-names>RM</given-names></name>
<name><surname>Wrobel</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Prospective analysis of surgical bone margins after partial foot amputation in diabetic patients admitted with moderate to severe foot infections</article-title>. <source>Foot Ankle Spec.</source>
<year>2019</year>;<volume>12</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>137</lpage>.<pub-id pub-id-type="pmid">29644884</pub-id>
</mixed-citation></ref><ref id="bibr33-15347346221122859"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agha</surname><given-names>RA</given-names></name>
<name><surname>Borrelli</surname><given-names>MR</given-names></name>
<name><surname>Vella-Baldacchino</surname><given-names>M</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>The STROCSS statement: Strengthening the reporting of cohort studies in surgery</article-title>. <source>Int J Surg.</source>
<year>2017</year>;<volume>46</volume>:<fpage>198</fpage>-<lpage>202</lpage>.<pub-id pub-id-type="pmid">28890409</pub-id>
</mixed-citation></ref><ref id="bibr34-15347346221122859"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sr JL</surname><given-names>M</given-names></name>
<name><surname>Conte</surname><given-names>MS</given-names></name>
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>The society for vascular surgery lower extremity threatened limb classification system: Risk stratification based on wound, ischemia, and foot infection (WIfI)</article-title>. <source>J Vasc Surg.</source>
<year>2014</year>;<volume>59</volume>(<issue>1</issue>):<fpage>220</fpage>-<lpage>234.e2</lpage>.<pub-id pub-id-type="pmid">24126108</pub-id>
</mixed-citation></ref><ref id="bibr35-15347346221122859"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lavery</surname><given-names>LA</given-names></name>
<name><surname>Armstrong</surname><given-names>DG</given-names></name>
<name><surname>Harkless</surname><given-names>LB</given-names></name>
</person-group>. <article-title>Classification of diabetic foot wounds</article-title>. <source>J Foot Ankle Surg.</source>
<year>1996</year>;<volume>35</volume>(<issue>6</issue>):<fpage>528</fpage>-<lpage>531</lpage>.<pub-id pub-id-type="pmid">8986890</pub-id>
</mixed-citation></ref><ref id="bibr36-15347346221122859"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chuan</surname><given-names>F</given-names></name>
<name><surname>Zhang</surname><given-names>M</given-names></name>
<name><surname>Yao</surname><given-names>Y</given-names></name>
<name><surname>Tian</surname><given-names>W</given-names></name>
<name><surname>He</surname><given-names>X</given-names></name>
<name><surname>Zhou</surname><given-names>B</given-names></name>
</person-group>. <article-title>Anemia in patients with diabetic foot ulcer: Prevalence, clinical characteristics, and outcome</article-title>. <source>Int J Low Extrem Wounds.</source>
<year>2016</year>;<volume>15</volume>(<issue>3</issue>):<fpage>220</fpage>-<lpage>226</lpage>.<pub-id pub-id-type="pmid">27440798</pub-id>
</mixed-citation></ref><ref id="bibr37-15347346221122859"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yesil</surname><given-names>S</given-names></name>
<name><surname>Akinci</surname><given-names>B</given-names></name>
<name><surname>Yener</surname><given-names>S</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Predictors of amputation in diabetics with foot ulcer: Single center experience in a large turkish cohort</article-title>. <source>Hormones</source>. <year>2009</year>;<volume>8</volume>(<issue>4</issue>):<fpage>286</fpage>-<lpage>295</lpage>.<pub-id pub-id-type="pmid">20045802</pub-id>
</mixed-citation></ref><ref id="bibr38-15347346221122859"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>T-W</given-names></name>
<name><surname>Calhoun</surname><given-names>EA</given-names></name>
<name><surname>Knapp</surname><given-names>SM</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Rates of diabetes-related Major amputations among racial and ethnic minority adults following medicaid expansion under the patient protection and affordable care act</article-title>. <source>JAMA Network Open</source>. <year>2022</year>;<volume>5</volume>(<issue>3</issue>):<comment>e223991</comment>-<lpage>e223991</lpage>.</mixed-citation></ref><ref id="bibr39-15347346221122859"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>T-W</given-names></name>
<name><surname>Shih</surname><given-names>C-D</given-names></name>
<name><surname>Concha-Moore</surname><given-names>KC</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Disparities in outcomes of patients admitted with diabetic foot infections</article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>(<issue>2</issue>):<comment>e0211481</comment>.</mixed-citation></ref><ref id="bibr40-15347346221122859"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narres</surname><given-names>M</given-names></name>
<name><surname>Kvitkina</surname><given-names>T</given-names></name>
<name><surname>Claessen</surname><given-names>H</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review</article-title>. <source>PloS one</source>. <year>2017</year>;<volume>12</volume>(<issue>8</issue>):<comment>e0182081</comment>.</mixed-citation></ref><ref id="bibr41-15347346221122859"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Neill</surname><given-names>SM</given-names></name>
<name><surname>Kabir</surname><given-names>Z</given-names></name>
<name><surname>McNamara</surname><given-names>G</given-names></name>
<name><surname>Buckley</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Comorbid depression and risk of lower extremity amputation in people with diabetes: Systematic review and meta-analysis</article-title>. <source>BMJ Open Diabetes Research and Care</source>. <year>2017</year>;<volume>5</volume>(<issue>1</issue>):<comment>e000366</comment>.</mixed-citation></ref><ref id="bibr42-15347346221122859"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yammine</surname><given-names>K</given-names></name>
<name><surname>Assi</surname><given-names>C</given-names></name>
</person-group>. <article-title>A meta-analysis of the types and outcomes of conservative excisional surgery for recalcitrant or infected diabetic toe ulcers</article-title>. <source>Foot Ankle Spec.</source>
<year>2020</year>;<volume>13</volume>(<issue>2</issue>):<fpage>152</fpage>-<lpage>160</lpage>.<pub-id pub-id-type="pmid">31216881</pub-id>
</mixed-citation></ref><ref id="bibr43-15347346221122859"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vassallo</surname><given-names>IM</given-names></name>
<name><surname>Gatt</surname><given-names>A</given-names></name>
<name><surname>Cassar</surname><given-names>K</given-names></name>
<name><surname>Papanas</surname><given-names>N</given-names></name>
<name><surname>Formosa</surname><given-names>C</given-names></name>
</person-group>. <article-title>Healing and mortality rates following toe amputation in type 2 diabetes mellitus</article-title>. <source>Exp Clin Endocrinol Diabetes.</source>
<year>2021</year>;<volume>129</volume>(<issue>06</issue>):<fpage>438</fpage>-<lpage>442</lpage>.<pub-id pub-id-type="pmid">31207664</pub-id>
</mixed-citation></ref><ref id="bibr44-15347346221122859"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Collins</surname><given-names>PM</given-names></name>
<name><surname>Joyce</surname><given-names>DP</given-names></name>
<name><surname>O&#x02019;Beirn</surname><given-names>ES</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Re-amputation and survival following toe amputation: Outcome data from a tertiary referral centre</article-title>. <source>Irish Journal of Medical Science (1971-)</source>. 2022;191(3):1193&#x02013;1199</mixed-citation></ref><ref id="bibr45-15347346221122859"><label>45</label><mixed-citation publication-type="journal">Schmidt BM, Holmes CM, Ye W, Pop-Busui R. A tale of two eras: Mining big data from electronic health records to determine limb salvage rates with podiatry. <italic toggle="yes">Curr Diabetes Rev</italic>. 2019;15(6):497&#x02013;502.</mixed-citation></ref><ref id="bibr46-15347346221122859"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blanchette</surname><given-names>V</given-names></name>
<name><surname>Brousseau-Foley</surname><given-names>M</given-names></name>
<name><surname>Cloutier</surname><given-names>L</given-names></name>
</person-group>. <article-title>Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: Systematic review and meta-analysis</article-title>. <source>J Foot Ankle Res.</source>
<year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>12</lpage>.<pub-id pub-id-type="pmid">31956341</pub-id>
</mixed-citation></ref><ref id="bibr47-15347346221122859"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monteiro-Soares</surname><given-names>M</given-names></name>
<name><surname>Vale-Lima</surname><given-names>J</given-names></name>
<name><surname>Martiniano</surname><given-names>J</given-names></name>
<name><surname>Pinheiro-Torres</surname><given-names>S</given-names></name>
<name><surname>Dias</surname><given-names>V</given-names></name>
<name><surname>Boyko</surname><given-names>EJ</given-names></name>
</person-group>. <article-title>A systematic review with meta-analysis of the impact of access and quality of diabetic foot care delivery in preventing lower extremity amputation</article-title>. <source>J Diabetes Complicat.</source> 2021;35(4):107837.</mixed-citation></ref></ref-list></back></article>